Thought Leadership
Latest News
 
Pills
June 29, 2015 Latham Counsels Juno Therapeutics in US$1 Billion Strategic Collaboration with Celgene Corporation
Team led from Silicon Valley guides the alignment of two major biopharma companies for the development and commercialization of immunotherapies to treat cancer and autoimmune diseases.
 
Latham & Watkins at a Glance
Diversity Matters